Seoulin Bioscience Co.,Ltd.
Research Seoulin Bioscience Co.,Ltd. (038070.KQ) on Bullrun: market cap KRW 33.60B, dividend yield 2.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker038070.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 33.60B
- Dividend yield2.6%
- Financial periodQ2 2026
- RevenueKRW 20.80B
- Net incomeKRW 342.21M
- Free cash flow-KRW 2.85B
- Gross margin17.5%
Valuation Snapshot
latest market cap is KRW 33.60B; dividend yield is 2.6%.
Peer valuation comparison
Latest dividend yield is 2.62% versus a Healthcare sector median of 2.4% (9.2% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 33.60B | n/a | 2.6% | 100 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 100 KRW, yield 2.6%.
About Seoulin Bioscience Co.,Ltd.
Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and functional cosmetics based on natural fermentation. Seoulin Bioscience Co.,Ltd.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Seoulin Bioscience Co.,Ltd.'s market cap?
Seoulin Bioscience Co.,Ltd.'s market capitalization is KRW 33.60B.
Does Seoulin Bioscience Co.,Ltd. pay a dividend?
Seoulin Bioscience Co.,Ltd. has a dividend yield of 2.6%.
What does Seoulin Bioscience Co.,Ltd. do?
Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and functional cosmetics based on natural fermentation. Seoulin Bioscience Co.,Ltd. was founded in 1984 and is headquartered in Seongnam-si, South Korea.